» Articles » PMID: 18038911

Anti-inflammatory Mechanisms of Apigenin: Inhibition of Cyclooxygenase-2 Expression, Adhesion of Monocytes to Human Umbilical Vein Endothelial Cells, and Expression of Cellular Adhesion Molecules

Overview
Journal Arch Pharm Res
Specialty Pharmacology
Date 2007 Nov 28
PMID 18038911
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to clarify the anti-inflammatory mechanism of apigenin. Apigenin inhibited the collagenase activity involved in rheumatoid arthritis (RA) and suppressed lipopolysaccharide (LPS)-induced nitric oxide (NO) production in a dose dependent manner in RAW 264.7 macrophage cells. Pretreatment with apigenin also attenuated LPS-induced cyclooxygenase-2 (COX-2) expression. In addition, apigenin profoundly reduced the tumor necrosis factor-alpha (TNF-alpha)-induced adhesion of monocytes to HUVEC monolayer. Apigenin significantly suppressed the TNF-alpha-stimulated upregulation of vascular cellular adhesion molecule-1 (VCAM-1)-, intracellular adhesion molecule-1 (ICAM-1)-, and E-selectin-mRNA to the basal levels. Taken together, these results suggest that apigenin has significant anti-inflammatory activity that involves blocking NO-mediated COX-2 expression and monocyte adherence. These results further suggest that apigenin may be useful for therapeutic management of inflammatory diseases.

Citing Articles

Bioferments Obtained by Fermentation with Kombucha as an Important Source of Active Substances for Skin Care.

Niziol-Lukaszewska Z, Ziemlewska A, Zagorska-Dziok M, Mokrzynska A, Wojciak M, Sowa I Molecules. 2025; 30(5).

PMID: 40076207 PMC: 11902125. DOI: 10.3390/molecules30050983.


Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38.

Lauritzen K, Yang K, Frisk M, Louwe M, Olsen M, Ziegler M Front Immunol. 2025; 15():1497984.

PMID: 39840045 PMC: 11746122. DOI: 10.3389/fimmu.2024.1497984.


Enhancement of in vitro transcellular absorption and in vivo oral bioavailability of apigenin by self-nanoemulsifying drug delivery systems.

Sato V, Sato H, Sangfuang M, Nontakham J, Junyaprasert V, Teeranachaideekul V Sci Rep. 2024; 14(1):32148.

PMID: 39738511 PMC: 11685950. DOI: 10.1038/s41598-024-84063-2.


The ethanolic extract of domesticated alleviated DSS-induced ulcerative colitis via repairing the intestinal barrier.

Kang J, Xie W, Wu L, Liu Y, Xu Y, Xu Y Food Sci Biotechnol. 2024; 33(14):3335-3345.

PMID: 39328223 PMC: 11422322. DOI: 10.1007/s10068-024-01565-5.


Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin.

Kumar G, Jain P, Virmani T, Sharma A, Akhtar M, Aldosari S Ther Deliv. 2024; 15(9):717-735.

PMID: 39259258 PMC: 11415023. DOI: 10.1080/20415990.2024.2386928.